Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·5d ago
More News
Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Integra (IART) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7d ago
Is This the Right Time to Hold IART Stock in Your Portfolio?
Integra shows growth promise from strong CSS demand and global expansion, but debt load and macro pressures raise concerns for investors.
Zacks·7d ago
AxoGen (AXGN) Q1 Earnings Lag Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of -41.67% and +4.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
Integra LifeSciences (IART) to Release Earnings on Tuesday
Integra LifeSciences (NASDAQ:IART) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat·7d ago
Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·12d ago
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Average Recommendation of "Reduce" from Analysts
Integra LifeSciences Holdings Corporation (NASDAQ:IART - Get Free Report) has been given an average recommendation of "Reduce" by the seven ratings firms that are covering the company, MarketBeat.com...
MarketBeat·14d ago
Why Integra (IART) is Poised to Beat Earnings Estimates Again
Integra (IART) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·18d ago
Integra LifeSciences (NASDAQ:IART) Shares Gap Down After Analyst Downgrade
Integra LifeSciences (NASDAQ:IART) Shares Gap Down on Analyst Downgrade...
MarketBeat·20d ago
Integra LifeSciences (NASDAQ:IART) Price Target Cut to $12.00 by Analysts at Truist Financial
Truist Financial lowered their target price on Integra LifeSciences from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Wednesday...